APA

Lawrence N., Martin A., Toner G., Stockler M., Buizen L., Thomson D., Gebski V., Friedlander M., Yeung A., Wong N., Gurney H., Rosenthal M., Singhal N., Kichenadasse G., Wong S., Lewis C., Vasey P. & Grimison P. (20180123). Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Lawrence N, Martin A, Toner G, Stockler M, Buizen L, Thomson D, Gebski V, Friedlander M, Yeung A, Wong N, Gurney H, Rosenthal M, Singhal N, Kichenadasse G, Wong S, Lewis C, Vasey P and Grimison P. 20180123. Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Lawrence N., Martin A., Toner G., Stockler M., Buizen L., Thomson D., Gebski V., Friedlander M., Yeung A., Wong N., Gurney H., Rosenthal M., Singhal N., Kichenadasse G., Wong S., Lewis C., Vasey P. and Grimison P. (20180123). Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Lawrence N, Martin A, Toner G, Stockler M, Buizen L, Thomson D, Gebski V, Friedlander M, Yeung A, Wong N, Gurney H, Rosenthal M, Singhal N, Kichenadasse G, Wong S, Lewis C, Vasey P and Grimison P. Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). : Annals of oncology : official journal of the European Society for Medical Oncology. 20180123.